These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 19380406

  • 21. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D, O'Neill BP, Subramaniam RM, Peller PJ, Witte RJ, Mullan BP, Wiseman GA.
    Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
    [Abstract] [Full Text] [Related]

  • 22. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 23. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
    Hallett WA, Maguire RP, McCarthy TJ, Schmidt ME, Young H.
    IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
    [Abstract] [Full Text] [Related]

  • 24. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, Kolodny G, Laham R.
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [Abstract] [Full Text] [Related]

  • 25. Breast cancer therapy: the role of PET-CT in decision making.
    Pons F, Duch J, Fuster D.
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):210-23. PubMed ID: 19293769
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy.
    Aukema TS, Vogel WV, Hoefnagel CA, Valdés Olmos RA.
    J Nucl Med Technol; 2010 Mar; 38(1):24-7. PubMed ID: 20159933
    [Abstract] [Full Text] [Related]

  • 28. Giant cell arteritis on 18F-FDG PET/CT.
    Heston TF, Szabo Z.
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
    [Abstract] [Full Text] [Related]

  • 29. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.
    J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
    Kobayashi N, Fujita K, Fujisawa T, Takahashi H, Yoneda M, Abe Y, Inamori M, Kirikoshi H, Kubota K, Saito S, Nakajima A.
    Gan To Kagaku Ryoho; 2008 Jan 01; 35(1):65-70. PubMed ID: 18195530
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose.
    Ceresoli GL, Chiti A, Zucali PA, Rodari M, Lutman RF, Salamina S, Incarbone M, Alloisio M, Santoro A.
    J Clin Oncol; 2006 Oct 01; 24(28):4587-93. PubMed ID: 17008700
    [Abstract] [Full Text] [Related]

  • 35. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
    Cheon GJ, Kim MS, Lee JA, Lee SY, Cho WH, Song WS, Koh JS, Yoo JY, Oh DH, Shin DS, Jeon DG.
    J Nucl Med; 2009 Sep 01; 50(9):1435-40. PubMed ID: 19690035
    [Abstract] [Full Text] [Related]

  • 36. [18F]FDG-PET-CT for early monitoring of tumor response: when and why.
    Storto G, Nicolai E, Salvatore M.
    Q J Nucl Med Mol Imaging; 2009 Apr 01; 53(2):167-80. PubMed ID: 19293765
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.